These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19651236)

  • 21. The ras gene family in human non-small-cell lung cancer.
    Slebos RJ; Rodenhuis S
    J Natl Cancer Inst Monogr; 1992; (13):23-9. PubMed ID: 1327034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.
    Slebos RJ; Hruban RH; Dalesio O; Mooi WJ; Offerhaus GJ; Rodenhuis S
    J Natl Cancer Inst; 1991 Jul; 83(14):1024-7. PubMed ID: 2072410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma.
    Okudela K; Hayashi H; Ito T; Yazawa T; Suzuki T; Nakane Y; Sato H; Ishi H; KeQin X; Masuda A; Takahashi T; Kitamura H
    Am J Pathol; 2004 Jan; 164(1):91-100. PubMed ID: 14695323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Morales E; Guarner L; Rifà J; Carrato A; Real FX;
    Environ Mol Mutagen; 2009 Jun; 50(5):421-30. PubMed ID: 19326463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.
    Westra WH; Offerhaus GJ; Goodman SN; Slebos RJ; Polak M; Baas IO; Rodenhuis S; Hruban RH
    Am J Surg Pathol; 1993 Mar; 17(3):213-20. PubMed ID: 8434702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
    Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
    Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
    Keohavong P; DeMichele MA; Melacrinos AC; Landreneau RJ; Weyant RJ; Siegfried JM
    Clin Cancer Res; 1996 Feb; 2(2):411-8. PubMed ID: 9816185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung.
    Ahrendt SA; Decker PA; Alawi EA; Zhu Yr YR; Sanchez-Cespedes M; Yang SC; Haasler GB; Kajdacsy-Balla A; Demeure MJ; Sidransky D
    Cancer; 2001 Sep; 92(6):1525-30. PubMed ID: 11745231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas.
    Gonzalez-Cadavid NF; Zhou D; Battifora H; Bar-Eli M; Cline MJ
    Oncogene; 1989 Sep; 4(9):1137-40. PubMed ID: 2674856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ras oncogenes in human cancer: a review.
    Bos JL
    Cancer Res; 1989 Sep; 49(17):4682-9. PubMed ID: 2547513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma.
    Iwakawa R; Kohno T; Anami Y; Noguchi M; Suzuki K; Matsuno Y; Mishima K; Nishikawa R; Tashiro F; Yokota J
    Clin Cancer Res; 2008 Jun; 14(12):3746-53. PubMed ID: 18559592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.